Monika Mittal

Dr. Monika Mittal is a dedicated researcher specializing in cancer biology, with a focus on acute myeloid leukemia (AML). With a strong background in molecular biology and biochemistry, Dr. Mittal aims to uncover the underlying mechanisms of blood cancers and develop innovative therapeutic strategies. Currently, Dr. Mittal is investigating the role of DCAF15, a protein that regulates cellular processes, to understand its impact on AML progression and treatment. By employing advanced techniques such as gene editing and targeted protein degradation, Dr. Mittal aims to create new therapeutic strategies that can improve patient outcomes. Passionate about translating scientific discoveries into clinical applications, Dr. Mittal is committed to improving outcomes for those affected by blood cancers, driving research forward to find more effective treatments for AML. Through collaboration and innovation, Dr. Mittal hopes to make a meaningful difference in the fight against leukemia.